Effect of continuous post-operative lidocaine infusion in an enhanced recovery program on opioid use following gynecologic oncology surgery
Journal of Gynecologic Oncology · 2023
DOI: 10.3802/jgo.2023.34.e61 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2023. Verfasst von Deanna Taiym und 5 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern University, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chicago, IL, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Genital Neoplasms, Female. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NICHD NIH HHS, NIA NIH HHS, NICHD.
Abstract (Originalsprache)
OBJECTIVE: To determine the effectiveness of implementing an Enhanced Recovery After Surgery (ERAS) program, including continuous intraoperative and postoperative intravenous (IV) lidocaine infusion, on perioperative opioid use. METHODS: This was a single-institution retrospective pre- post- cohort study. Consecutive patients undergoing planned laparotomy for known or potential gynecologic malignancy were identified after implementation of an ERAS program and compared to a historical cohort. Opioid use was calculated as morphine milligram equivalents (MMEs). Cohorts were compared using bivariate tests. RESULTS: A total of 215 patients were included in the final analysis, 101 patients received surgery before ERAS implementation and 114 received surgery after. A reduction in total opioid use was observed in ERAS patients compared with historical controls (MME 26.5 [9.6-60.8] versus 194.5 [123.8-266.8], p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northwestern University, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chicago, IL, USA.
- Albert Einstein College of Medicine, Division of Gynecologic Oncology, Montefiore Medical Center, Department of Obstetrics and Gynecology and Women's Health, Bronx, NY, USA.
- Department of Obstetrics and Gynecology, Columbia University Medical Center, NewYork-Presbyterian Hospital, New York, NY, USA.
- Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cleveland, OH, USA.
- Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
- Surgical Outcomes and Quality Improvement Center, Institute for Public Health in Medicine, Chicago, IL, USA. emma.barber@northwestern.edu.
ORCID-Profile: Deanna Taiym, Matthew Cowan, Brad Nakamura, Hooman Azad, Emma Barber
Förderung
- NICHD NIH HHS
- NIA NIH HHS
- NICHD
- NIA
- GOG Foundation
Zitieren
APA
Taiym, D., Cowan, M., Nakamura, B., Azad, H., Strohl, A., & Barber, E. (2023). Effect of continuous post-operative lidocaine infusion in an enhanced recovery program on opioid use following gynecologic oncology surgery. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2023.34.e61
Vancouver
Taiym D, Cowan M, Nakamura B, Azad H, Strohl A, Barber E. Effect of continuous post-operative lidocaine infusion in an enhanced recovery program on opioid use following gynecologic oncology surgery. Journal of Gynecologic Oncology. 2023. doi:10.3802/jgo.2023.34.e61
BibTeX
@article{Taiym2023,
author = {Taiym, Deanna and Cowan, Matthew and Nakamura, Brad and Azad, Hooman and Strohl, Anna and Barber, Emma},
title = {Effect of continuous post-operative lidocaine infusion in an enhanced recovery program on opioid use following gynecologic oncology surgery},
journal = {Journal of Gynecologic Oncology},
year = {2023},
doi = {10.3802/jgo.2023.34.e61}
}
EUVIMED